Mereo BioPharma Group plc Quarterly Interest Expense in USD from Q1 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Mereo BioPharma Group plc quarterly/annual Interest Expense history and growth rate from Q1 2023 to Q2 2024.
  • Mereo BioPharma Group plc Interest Expense for the quarter ending June 30, 2024 was $331K, a 67.8% decline year-over-year.
  • Mereo BioPharma Group plc annual Interest Expense for 2023 was $2.88M, a 31% decline from 2022.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $331K -$698K -67.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $310K -$490K -61.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q2 2023 $1.03M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $800K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.